骨质疏松症的防治研究进展

www.yongyao.net　　2009-8-27 10:59:32　　来源：　　责任编辑：

分享到：

参考文献
〔1〕　赵冀伟.骨质疏松药物治疗概述[J ].天津药学,2004 ,16(2) :683 2 684.
〔2〕　赵伟业,董碧蓉,欧雪梅,等. 骨质疏松症药物治疗的新进展及循证证据[J ] . 中国骨质疏松杂志,2003 ,9 (1) :80 2 82.
〔3〕　余自成. 骨质疏松症预防和治疗药物的选择[ J ] . 上海医药,2004 ,25 (5) :2 2 5.
〔4〕　徐苓,林守清,邢淑敏,等.“HRT 临床应用指南”研讨会会议纪要,中华医学会妇产科分会绝经学组[J ] .《性激素补充疗法临床应用指南(2003 年) 》, 2003 年8 月30 日.
〔5〕　REGINSTER J Y. Treatment of postmenopausal osteoporosis[J ] . BMJ ,2005 ,330 (7505) :859 2 860.
〔6〕　REGINSTER J Y, DEVOGELAER J P. Raloxifene reducesf ractures in postmenopausal women wit h osteoporosis [ J ] . ClinOrt hop Relat Res ,2006 , 443 :48 2 54.
〔7〕　MCCLUNG M R ,SIRIS E,CUMMINGS S , et al. Prevention of boneloss inpostmenopausal women treated with lasofoxifene compared with raloxifene[J ].Menopause ,2006 ,13 (3) :377 2 386.
〔8〕　MC CLOSKEY SEBY P ,DETAKATS DETAL . Effect of ciodronate on verebral fracture risk in osteoporosis :a year in terim[J ]. Analysis Bone ,2001 ,28(3) :310 2 312.
〔9〕　CAUL EY J A ,NORTON L ,L IPPMAN M E , et al . Continued breast cancer risk reduction in poetmenopausal women t reated with raloxifene :4 2 year result s f rom t he MORE t rial . Multiple
outcomes of raloxifene evaluation[J ] . Breast Cancer Res Treat ,2001 ,65 (2) :125 2 134.
〔10〕　张小玉,王雷,陆重琳,等. 雷洛昔芬治疗慢性肝病发发骨质疏松症患者40 例分析[J ] . 实用医学杂志,2005 ,21 (3) :306 2 307.
〔11〕　张燕燕,卢春燕,陈德才,等. 抗骨质疏松症药物研究进展[J ] .西部医学,2007 , 19 (1) :139 2 140.
〔12〕　ANN CRANNEY,PETER TU GWELL ,NICOL E ZYTARU K,et al . Meta2 analysis of calcitonin for t he t reatment of postmenopausal osteoporosis [ J ] . Endocrine Reviews ,2002 ,23(4) :540 2 551.
〔13〕　BONNICK S , SAAG K G, KIEL D P , et al . Comparison of postmenopausal osteoporosis wit h alendronate versus risedronate over two years [J ] . J Clin Endocrinol Melab ,2006 ,91 (7) :2631 2 2637.
〔14〕　TAN KO L B , FELSNBERG D , CZERWINSKI E , et al . Oral weekly ibandronate prevent s bone loss in postmenoausal women[J ] . J Intern Med ,2003 ,254 (2) :159 2 162.
〔15〕　ANN CRANNEY,AL EXANDRA PAPAIOANNOU ,NICOL EZYTARU K,et al . Parat hyroid hormone for t he t reatment of osteoporosis :a systematic review[ J ] . CMAJ , 2006 ,175 ( 1) :52259.
〔16〕　王红,吴红菱. 他汀类药物刺激骨形成的作用[ J ] . 医药导报,2002 ,21 (10) :265.
〔17〕　邵利民. 氨基酸螯合钙治疗老年妇女骨质疏松症临床对比观察[J ] . 实用妇科杂志, 2004 ,20 (4) :254.
〔18〕　WINZENBERG T , SHAW K, FRYER J , et al . Effect s of calcium supplementation on bone density in healt hy children meta2 analysis of randomised cont rolled t rials[J ] . BMJ ,2006 ,333 (7572) :775.
〔19〕　PORTHOUS J ,COCKA YNE S , KING C , et al . Randomised cont rolled t rial of calcium and supplementation wit hcholecalciferol ( vitamin D3 ) for prevention of f ractures in primary care[J ] . BMJ , 2005 , 330 ( 7498) :1003.
〔20〕　FRANCE R M. Calcium, vitamin D and involutional osteoporosis.Current Opinion in Clinical[J ]. Nutrition &Metabolic Care ,2006 ,9(1) :13 2 17.
〔21〕　姚朗. 他汀类调血脂药物的潜在新作用———抗骨质疏松[J ] . 中国新药与临床杂志,2002 ,21 (4) :249.
〔22〕　TOURNIS S , ECONOMOPOULOS D , LYRITIS G P. Strontium ranelate :anovel treatment in postmenopausal osteoporosis [J ]. AnnN Y Acad Sci ,2006 ,1092 :403 2 407.
〔23 〕　DOGGRELL S A. Present and future pharmacot herapy for osteoporosis[J ] . Drugs Today(Barc) ,2003 ,39 (8) :633.
〔24〕　周兴茂,杨海韵. 骨质疏松症的中医学研究进展[J ] . 中国中医骨伤科杂志,2007 ,15 (3) :60.
〔25〕　胡柏平,郑现杰. 骨质疏松症防治的研究现状及展望[J ] . 山西师大体育学院学报,2007 ,2 (6) :22.
〔26〕　张林,杨锡让. 运动员骨密度变化特点[ J ] . 中国体育科技,1999 ,34 (3) :14 2 16.
〔27〕　周勇,李靖,陈一冰,等. 太极推手锻炼与补钙对绝经女性骨密度的影响[J ] . 中国运动医学杂志,2005 ,24 (1) :106 2 108.
〔28〕　PIETU G, ALIBERT O , GUICHARD V , et al . Novel genet ranscrip t sp referentially exp ressed in humanmuscles revealed by quantitative hybridization of a high density cDNA array[J ] .Genome Res ,1996 ,6 :482 2 503.